January 31, 2023
Otsuka Pharmaceutical said on January 30 that it has filed an application seeking an additional indication for its atypical antipsychotic Rexulti (brexpiprazole) for the treatment of certain patients with depression and depressive state in Japan. The company is seeking the...read more